Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CRISPR/Cas9 therapeutics for liver diseases.

Journal of cellular biochemistry - 1 Jun 2018

Aravalli Rajagopal N, Steer Clifford J

Abstract excerpt

The development of innovative genome editing techniques in recent years has revolutionized the field of biomedicine. Among the novel approaches, the clustered regularly interspaced short palindromic repeat/CRISPR-associated protein (CRISPR/Cas9) technology has become the most popular, in part due to its matchless ability to carry out gene editing at the target site with great precision. With considerable...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR-Cas Systems
Share to Gene Editing
Share to Genetic Diseases, Inborn

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Liver Diseases

Share to Mutation

Source

Identifiers

PMID: 29266637
DOI: 10.1002/jcb.26627

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CRISPR/Cas9 therapeutics for liver diseases.PMID 29266637Read ↗

CRISPR/Cas9: at the cutting edge of hepatology.Semantic proximity Read ↗

In vivo liver targeted genome editing as therapeutic approach: progresses and challengesSemantic proximity Read ↗

Emerging and potential use of CRISPR in human liver diseaseSemantic proximity Read ↗

Advanced Nanotheranostics of CRISPR/Cas for Viral Hepatitis and Hepatocellular CarcinomaSemantic proximity Read ↗

Genome editing: A perspective on the application of CRISPR/Cas9 to study human diseases (Review)Semantic proximity Read ↗

Clinical applications of the CRISPR/Cas9 genome-editing system: Delivery options and challenges in precision medicineSemantic proximity Read ↗

Description of CRISPR/Cas9 development and its prospect in hepatocellular carcinoma treatmentSemantic proximity Read ↗

CRISPR/Cas gene therapy.Semantic proximity Read ↗

CRISPR/Cas9-mediated genome editing: From basic research to translational medicine.Semantic proximity Read ↗

Research progress and application of the CRISPR/Cas9 gene-editing technology based on hepatocellular carcinomaSemantic proximity Read ↗

Progress and Perspective of CRISPR‐Cas9 Technology in Translational MedicineSemantic proximity Read ↗

Advancements in CRISPR/Cas systems for disease treatmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.